Company profilePharmaceutical#546 of 1,318 in Pakistan✓ No DRAP alerts

News Pharma

Pharmaceutical company · 23 brands · 21 molecules

23 registered products 14 pharmaceutical brands 21 distinct molecules 0 DRAP alerts

Company overview

23
registered products
14
pharmaceutical brands
21
distinct molecules
0
therapeutic classes
0
DRAP alerts

News Pharma is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 23 product registrations across 21 distinct molecules. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by News

11 products matched in our catalogue — each with its observed price and DRAP approved ceiling.

Price ceiling age

DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.

9
ceilings with an approval date
9
not revised in 2+ years
2024
oldest approval year
20249
Longest without revision

Top molecules by brand count

Cefixime2 brands
Ceftazidime Pentahydrate ...... 500 Mg1 brand
Amikacin ...... 500 Mg1 brand
Trimethoprim ...... 40 Mg1 brand
Furosemide ...... 20 Mg1 brand
Ceftazidime Pentahydrate ...... 1 Gm1 brand
Furosemide1 brand

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official23 products · Rs 29.46 – Rs 740.66
Median across source: Rs 202.92

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

AKSON PHARMACEUTICALS (PVT) LTD. holds 49 molecules not in this portfolio
000 I.UAtropineAzithromycinCefiximeCefotaximeCefotaxime Sodium
Martin Dow Pharmaceuticals (Pvt) Ltd. holds 142 molecules not in this portfolio
AlfacalcidolAmlodipineApixabanAspirinAzithromycinBetamethasone
ZAFA PHARMACEUTICAL LABORATORIES (PVT) LTD. holds 151 molecules not in this portfolio
AlbuterolAminophyllineAmlodipineAmlodipine BaseAmmonium ChlorideAmmonium Chloride Containing Expectorants

Get the full profile for News

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.